Paradigm, Strategies In Wealth Management, LLC Senseonics Holdings, Inc. Transaction History

Paradigm, Strategies In Wealth Management, LLC

$153 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$1.54 - $3.71 $104,268 - $251,192	-67,707 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$2.77 - $4.05 $75,344 - $110,160	27,200 Added 67.15%	67,707 $230,000
Q2 2021 Jul 30, 2021	BUY	$1.71 - $4.14 $60,716 - $146,998	35,507 Added 710.14%	40,507 $156,000
Q1 2021 Apr 29, 2021	BUY	$0.85 - $5.27 $4,250 - $26,349	5,000 New	5,000 $13,000

Others Institutions Holding SENS

# of Institutions

140

Shares Held

59.9M

Call Options Held

393K

Put Options Held

254K

Vanguard Group Inc Valley Forge, PA

23.5M
Shares

$18.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.32M
Shares

$6.49 Million
0.0% of portfolio
Masters Capital Management LLC Atlanta, GA

7M
Shares

$5.46 Million
0.12% of portfolio
Geode Capital Management, LLC Boston, MA

5.84M
Shares

$4.55 Million
0.0% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

3.06M
Shares

$2.39 Million
0.0% of portfolio

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm, Strategies In Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm, Strategies In Wealth Management, LLC with notifications on news.

Account